文献速递临床试验与 GCP

全腹腔镜左半肝切除术对比开腹左半肝切除术治疗原发性左侧肝胆管结石:随机对照试验研究方案

Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-02-22

该随机对照试验拟比较全腹腔镜左半肝切除术(LLH)与开腹左半肝切除术(OLH)治疗肝胆管结石的安全性和有效性,所有患者均在加速康复外科(ERAS)方案下手术。主要结局为术后住院时间(LOS),假设LLH可缩短住院1天,每组需86例(90%把握度,α=0.05双侧)。试验注册号NCT03958825,注册日期2019年5月21日。

要点

  • LLH对比OLH治疗肝胆管结石的住院时间、并发症、远期腹壁疝等优势尚未经随机对照试验证实。
  • 主要结局为术后住院时间,假设LLH可缩短1天,每组86例(90%把握度,α=0.05双侧)。
  • 所有患者均在ERAS方案下手术,另设前瞻性登记组纳入无法随机或不符合标准的患者。

核心结论

  • 尽管回顾性研究显示LLH的结局与OLH相当,但LLH的应用仍受限,部分原因是缺乏针对肝胆管结石患者在ERAS方案下的短期和长期信息性随机对照试验。
  • 本试验将在ERAS方案下前瞻性随机比较LLH与OLH治疗肝胆管结石的手术和长期结局。

研究设计与样本

  • 随机对照试验,设两个随机分组(腹腔镜与开腹左半肝切除术),按1:1比例分配,另设前瞻性登记组。
  • 前瞻性登记组基于因患者或术者明确治疗偏好或不符合本试验随机化纳入和排除标准而无法随机化的患者。
  • 样本量:每个随机分组86例,足以检测住院时间缩短1天(90%把握度,α=0.05双侧)。
  • 所有患者均在加速康复外科(ERAS)方案下手术。
  • 试验注册:ClinicalTrials.gov NCT03958825,注册日期2019年5月21日。

主要发现

  • 主要结局为术后住院时间(LOS)。
  • 次要结局包括再入院百分比、并发症率、死亡率、住院费用、远期切口疝发生率、残石率和结石复发率。
  • 假设接受LLH的患者住院时间缩短1天。

关键数值与推荐

  • 主要结局为术后住院时间(LOS)。
  • 次要结局为再入院百分比、并发症率、死亡率、住院费用、远期切口疝发生率、残石率和结石复发率。
  • 样本量计算:每个随机分组86例,检测住院时间缩短1天,90%把握度,α=0.05(双侧)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The advantages of laparoscopic left-sided hepatectomy (LLH) for treating hepatolithiasis in terms of the time to postoperative length of hospital stay (LOS), morbidity, long-term abdominal wall hernias, hospital costs, residual stone rate, and recurrence of calculus have not been confirmed by a randomized controlled trial. The aim of this trial is to compare the safety and effectiveness of LLH with open left-sided hepatectomy (OLH) for the treatment of hepatolithiasis. METHODS: Patients with hepatolithiasis eligible for left-sided hepatectomy will be recruited. The experimental design will produce two randomized arms (laparoscopic and open hepatectomy) at a 1:1 ratio and a prospective registry. All patients will undergo surgery in the setting of an enhanced recovery after surgery (ERAS) programme. The prospective registry will be based on patients who cannot be randomized because of the explicit treatment preference of the patient or surgeon or because of ineligibility (not meeting the inclusion and exclusion criteria) for randomization in this trial. The primary outcome is the LOS. The secondary outcomes are percentage readmission, morbidity, mortality, hospital costs, long-term incidence of incisional hernias, residual stone rate, and recurrence of calculus. It will be assumed that, in patients undergoing LLH, the length of hospital stay will be reduced by 1 day. A sample size of 86 patients in each randomization arm has been calculated as sufficient to detect a 1-day reduction in LOS [90% power and α = 0.05 (two-tailed)]. The trial is a randomized controlled trial that will provide evidence for the merits of laparoscopic surgery in patients undergoing liver resection within an ERAS programme. CONCLUSIONS: Although the outcomes of LLH have been proven to be comparable to those of OLH in retrospective studies, the use of LLH remains restricted, partly due to the lack of short- and long-term informative RCTs pertaining to patients with hepatolithiasis in ERAS programmes. To evaluate the surgical and long-term outcomes of LLH, we will perform a prospective RCT to compare LLH with OLH for hepatolithiasis within an ERAS programme. TRIAL REGISTRATION: ClinicalTrials.gov NCT03958825. Registered on 21 May 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pan SB, Wu CL, Zhou DC, et al. Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: study protocol for a randomized controlled trial. Trials. 2024. PMID: 38383461. doi:10.1186/s13063-023-07476-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。